TEMODAR Side Effects

7007688-X | Blood Potassium Decreased, Blood Sodium Decreased, Carbon Dioxide Decreased, Clonus, Hydrocephalus, Hyperreflexia, Hypothyroidism, Meningitis, Muscle Twitching
on Sep 13, 2010 Male patient from UNITED STATES , 70 years of age, weighting 208.0 lb, was diagnosed with glioblastoma, urinary tract infection (What is urinary tract infection?) and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, blood sodium decreased, carbon dioxide decreased, clonus, hydrocephalus (What is hydrocephalus?), hyperreflexia, hypothyroidism, meningitis (What is meningitis?), muscle twitching. Temodar dosage: 420 Mg; Po. During the same period patient was treated with SARGRAMOSTIM (0.35 Mcg;qm;id) (View Sargramostim Review and Sargramostim Label ), ACYCLOVIR SODIUM (900 Mg;qd;iv; 800 Mg;qd;iv) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized and became disabled.

7006370-2 | Bone Marrow Failure, Pancytopenia, Vitamin B Complex Deficiency
Patient was taking Temodar (View Usage). Patient had the following side effects: bone marrow failure, pancytopenia, vitamin b complex deficiency on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with glioblastoma and. Temodar dosage: ;po. During the same period patient was treated with REMERON (View Remeron Review and Remeron Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), REGLAN (View Reglan Review and Reglan Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), MACROCRYSTAL (View Macrocrystal Review and Macrocrystal Label ).

6970328-X | Febrile Neutropenia, Pulmonary Embolism
Adverse event was reported on Aug 25, 2010 by a Female patient taking Temodar (View Usage) (Dosage: 75 Mg; Qd; Po) was diagnosed with glioblastoma and. Location: UNITED STATES , 57 years of age, After Temodar was administered, patient had the following side effects: febrile neutropenia, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6966201-3 | Abdominal Discomfort, Abdominal Distension, Alanine Aminotransferase Increased, Back Pain, Blood Pressure Increased, Brain Mass, Cerebral Haemorrhage, Chest Pain, Cholelithiasis
on Aug 26, 2010 Male patient from UNITED STATES , 45 years of age, weighting 205.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal distension, alanine aminotransferase increased, back pain (What is back pain?), blood pressure increased, brain mass, cerebral haemorrhage, chest pain (What is chest pain?), cholelithiasis. Temodar dosage: 100 Mg Qd Po; 100 Mg Qd Po; 100 Mg/m2 Qd Po; 75 Mg/m2 Qd Po; 75 Mg/m2 Qd Po. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.


6964088-6 | Haematuria, Platelet Count Decreased
on Oct 04, 2006 Female patient from ITALY , 51 years of age, weighting 152.1 lb, was diagnosed with malignant melanoma and was treated with Temodar (View Usage). Patient had the following side effects: haematuria, platelet count decreased. Temodar dosage: 350 Mg;qd;po. Patient was hospitalized.

6945783-1 | Haematuria, Platelet Count Decreased
Patient was taking Temodar (View Usage). After Temodar was administered, patient had the following side effects: haematuria, platelet count decreased on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 152.1 lb, was diagnosed with malignant melanoma and. Temodar dosage: 350 Mg;qd;po ; 350 Mg;qd;po. Patient was hospitalized.

6929171-X | Myocardial Infarction
Adverse event was reported on Aug 06, 2010 by a Male patient taking Temodar (View Usage) (Dosage: ) was diagnosed with malignant melanoma and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. Patient was hospitalized.

6923043-2 | Small Intestinal Obstruction
on Aug 05, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Temodar (View Usage). Patient had the following side effects: small intestinal obstruction. Temodar dosage: . Patient was hospitalized.

6919542-X | Chills, Diarrhoea, Hypoaesthesia, Nausea, Sensation Of Heaviness
on Aug 10, 2010 Female patient from UNITED STATES , 54 years of age, weighting 107.0 lb, was diagnosed with malignant melanoma and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: chills, diarrhoea, hypoaesthesia, nausea (What is nausea?), sensation of heaviness. Temodar dosage: 300mg Daily Po.

6899681-2 | Abdominal Discomfort, Abdominal Distension, Chest Pain, Cholelithiasis, Diarrhoea, Dyspnoea, Gastrointestinal Disorder, Headache, Hepatic Steatosis
Patient was taking Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal distension, chest pain (What is chest pain?), cholelithiasis, diarrhoea, dyspnoea, gastrointestinal disorder, headache (What is headache?), hepatic steatosis on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 205.7 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence and. Temodar dosage: 100mg/m2 Daily Oral. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6881392-0 | Malignant Neoplasm Progression, Simple Partial Seizures
Adverse event was reported on Jul 28, 2010 by a Male patient taking Temodar (View Usage) (Dosage: 145mg Daily Oral) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , weighting 165.1 lb, Patient had the following side effects: malignant neoplasm progression, simple partial seizures. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ), RT WITH CONCURRENT TEMODAR (View Rt With Concurrent Temodar Review and Rt With Concurrent Temodar Label ), ADJUVANT TEMODAR (View Adjuvant Temodar Review and Adjuvant Temodar Label ), DOSE INTENSE TEMODAR (View Dose-intense Temodar Review and Dose-intense Temodar Label ). Patient was hospitalized.

6881388-9 | Back Pain, Pulmonary Embolism, Pyrexia, Sinus Tachycardia
on Jul 28, 2010 Male patient from UNITED STATES , weighting 206.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: back pain (What is back pain?), pulmonary embolism (What is pulmonary embolism?), pyrexia, sinus tachycardia. Temodar dosage: 200mg Daily Oral. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NYSTATIN (View Nystatin Review and Nystatin Label ). Patient was hospitalized.

6881362-2 | Abdominal Discomfort, Alanine Aminotransferase Increased, Chest Pain, Decreased Appetite, Diarrhoea, Dyspnoea, Electrocardiogram Qt Prolonged, Headache
on Jul 28, 2010 Male patient from UNITED STATES , weighting 205.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, alanine aminotransferase increased, chest pain (What is chest pain?), decreased appetite, diarrhoea, dyspnoea, electrocardiogram qt prolonged, headache (What is headache?). Temodar dosage: 100mg/m2 Daily Oral. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6881360-9 | Gait Disturbance, Headache, Incontinence, Lymphocyte Count Abnormal
Patient was taking Temodar (View Usage). Patient had the following side effects: gait disturbance, headache (What is headache?), incontinence, lymphocyte count abnormal on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 157.9 lb, was diagnosed with glioblastoma multiforme and. Temodar dosage: 100mg/m2 Daily Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), EFFEXOR (View Effexor Review and Effexor Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PROTONIX (View Protonix Review and Protonix Label ), KEPPRA (View Keppra Review and Keppra Label ), ZOFRAN (View Zofran Review and Zofran Label ), COLACE (View Colace Review and Colace Label ).

6863595-4 | Brain Neoplasm Malignant, Disease Complication
Adverse event was reported on Jul 14, 2010 by a Female patient taking Temodar (View Usage) (Dosage: ) was diagnosed with nervous system disorder and. Location: UNITED STATES , 55 years of age, After Temodar was administered, patient had the following side effects: brain neoplasm malignant, disease complication.

6863384-0 | Oncologic Complication
on Jul 14, 2010 Female patient from UNITED STATES , 55 years of age, was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: oncologic complication. Temodar dosage: .

6836804-5 | Aphagia, Blood Potassium Decreased, Body Temperature Increased, Clonus, Cytomegalovirus Infection, Epstein-barr Virus Infection, Glioblastoma, Haematocrit Decreased, Haemoglobin Decreased
on Jul 02, 2010 Male patient from UNITED STATES , 70 years of age, weighting 208.0 lb, was diagnosed with glioblastoma and was treated with Temodar (View Usage). Patient had the following side effects: aphagia, blood potassium decreased, body temperature increased, clonus, cytomegalovirus infection (What is cytomegalovirus infection?), epstein-barr virus infection, glioblastoma, haematocrit decreased, haemoglobin decreased. Temodar dosage: 420 Mg; ; Po. During the same period patient was treated with SARGRAMOSTIM (0.35 Mcg; Qm; Id) (View Sargramostim Review and Sargramostim Label ), ACYCLOVIR (900 Mg; Qd; Iv) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ). Patient was hospitalized and became disabled.

6773571-8 | Abdominal Distension, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Glucose Increased, Brain Oedema, Cholelithiasis, Decreased Appetite, Diarrhoea
Patient was taking Temodar (View Usage). After Temodar was administered, patient had the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood glucose increased, brain oedema, cholelithiasis, decreased appetite, diarrhoea on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 45 years of age, weighting 205.7 lb, was diagnosed with disease recurrence, glioblastoma multiforme and. Temodar dosage: 100 Mg; Qd; Po, 100 Mg/m2; Qd; Po. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6770394-0 | Abdominal Discomfort, Back Pain, Chest Pain, Decreased Appetite, Diarrhoea, Headache, Hyperglycaemia, Hypokalaemia, Nausea
Adverse event was reported on Jun 07, 2010 by a Male patient taking Temodar (View Usage) (Dosage: 100 Mg; Qd; Po, 100 Mg/m2; Qd; Po) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 45 years of age, weighting 205.7 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, back pain (What is back pain?), chest pain (What is chest pain?), decreased appetite, diarrhoea, headache (What is headache?), hyperglycaemia, hypokalaemia, nausea (What is nausea?). During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ), TYLENOL (View Tylenol Review and Tylenol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6770313-7 | Respiratory Distress
on Jun 02, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with malignant melanoma and was treated with Temodar (View Usage). Patient had the following side effects: respiratory distress. Temodar dosage: .

6770277-6 | Clonus, Haematocrit Decreased, Haemoglobin Decreased, Hydrocephalus, Hyperreflexia, Hypothyroidism, Mental Status Changes, Muscle Twitching, Musculoskeletal Stiffness
on Jun 07, 2010 Male patient from UNITED STATES , 70 years of age, weighting 208.0 lb, was diagnosed with glioblastoma and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: clonus, haematocrit decreased, haemoglobin decreased, hydrocephalus (What is hydrocephalus?), hyperreflexia, hypothyroidism, mental status changes, muscle twitching, musculoskeletal stiffness. Temodar dosage: 420 Mg; Po. During the same period patient was treated with PF 04948568 (Id) (View Pf-04948568 Review and Pf-04948568 Label ), SARGRAMOSTIM (Id) (View Sargramostim Review and Sargramostim Label ), ACYCLOVIR (900 Mg; Qd; Iv) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ). Patient was hospitalized and became disabled.

6770240-5 |
Patient was taking Temodar (View Usage). on Jun 01, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with malignant melanoma and. Temodar dosage: .

6768895-4 | Atelectasis, Disease Progression, Failure To Thrive, Hypophagia, Pleural Effusion
Adverse event was reported on May 28, 2010 by a Male patient taking Temodar (View Usage) (Dosage: 135 Mg;) was diagnosed with brain neoplasm and. Location: UNITED STATES , 54 years of age, weighting 137.2 lb, Patient had the following side effects: atelectasis, disease progression, failure to thrive, hypophagia, pleural effusion. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), GLUCOSE (View Glucose Review and Glucose Label ). Patient was hospitalized.

6745164-X | Deep Vein Thrombosis
on May 19, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Temodar dosage: 400 Mg; Po, 200 Mg; Po.

6743557-8 | Asthenia, Fall, Muscular Weakness
on May 26, 2010 Male patient from UNITED STATES , weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, fall (What is fall?), muscular weakness. Temodar dosage: 140 Mg (75 Mg/m2) Daily Po. During the same period patient was treated with PACLITAXEL (78 Mg (40 Mg/m2) Wkly X 6 Iv) (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6740757-8 | Caustic Injury, Gingival Swelling, Regurgitation, Swollen Tongue, Tongue Blistering
Patient was taking Temodar (View Usage). Patient had the following side effects: caustic injury, gingival swelling, regurgitation, swollen tongue, tongue blistering on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 23 years of age, was diagnosed with mixed oligo-astrocytoma and. Temodar dosage: 460 Mg Qd Po. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), ZOFRAN (View Zofran Review and Zofran Label ), DILANTIN (View Dilantin Review and Dilantin Label ), COMPAZINE (View Compazine Review and Compazine Label ).

6733381-4 | Connective Tissue Disorder, Disease Progression
Adverse event was reported on May 14, 2010 by a Male patient taking Temodar (View Usage) (Dosage: ) was diagnosed with connective tissue disorder (What is connective tissue disorder?) and. Location: UNITED STATES , 40 years of age, After Temodar was administered, patient had the following side effects: connective tissue disorder (What is connective tissue disorder?), disease progression.

6733113-X | Blood Creatinine Increased, Haemoglobin Decreased, Interstitial Lung Disease, Pneumonia Primary Atypical, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on May 13, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, haemoglobin decreased, interstitial lung disease, pneumonia primary atypical, red blood cell count decreased, white blood cell count decreased. Temodar dosage: 3 Df; Po. During the same period patient was treated with THALOMID (50 Mg; Hs; Po) (View Thalomid Review and Thalomid Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), VIAGRA (View Viagra Review and Viagra Label ), PATANOL (View Patanol Review and Patanol Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LOTENSIN (View Lotensin Review and Lotensin Label ). Patient was hospitalized.

6724770-2 |
on May 06, 2010 Male patient from UNITED STATES , 40 years of age, was diagnosed with connective tissue disorder (What is connective tissue disorder?) and was treated with Temodar (View Usage). . Temodar dosage: .

6720621-0 | Hepatitis
Patient was taking Temodar (View Usage). After Temodar was administered, patient had the following side effects: hepatitis (What is hepatitis?) on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, . Temodar dosage: 75 Mg. Patient was hospitalized.

6717264-1 |
Adverse event was reported on Apr 28, 2010 by a Male patient taking Temodar (View Usage) (Dosage: ) was diagnosed with brain neoplasm and. Location: UNITED STATES , 54 years of age, .

6705965-0 | Gingival Swelling, Swollen Tongue, Tongue Blistering
on Apr 21, 2010 Male patient from UNITED STATES , 23 years of age, was diagnosed with gliomatosis cerebri and was treated with Temodar (View Usage). Patient had the following side effects: gingival swelling, swollen tongue, tongue blistering. Temodar dosage: 460 Mg;qd;po. During the same period patient was treated with TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), NORTRIPTYLINE /00006502/ (View Nortriptyline /00006502/ Review and Nortriptyline /00006502/ Label ), PRILOSEC /00661201/ (View Prilosec /00661201/ Review and Prilosec /00661201/ Label ), ZOFRAN (View Zofran Review and Zofran Label ), DILANTIN (View Dilantin Review and Dilantin Label ), COMPAZINE (View Compazine Review and Compazine Label ).

6703036-0 | Gait Disturbance
on Apr 20, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with metastatic malignant melanoma and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: gait disturbance. Temodar dosage: Po.

6697731-X | Brain Neoplasm, Neoplasm Progression
Patient was taking Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: brain neoplasm, neoplasm progression on Apr 20, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with glioblastoma multiforme and. Temodar dosage: 280 Mg;qd;po.

6694262-8 |
Adverse event was reported on Apr 16, 2010 by a Female patient taking Temodar (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 55 years of age, .

6673841-8 |
on Apr 05, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with brain neoplasm and was treated with Temodar (View Usage). . Temodar dosage: .

6673840-6 | Fluid Retention
on Apr 02, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with endometrial cancer and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: fluid retention. Temodar dosage: .

6673131-3 |
Patient was taking Temodar (View Usage). on Apr 02, 2010 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with malignant melanoma and. Temodar dosage: .

6666193-0 | Aplastic Anaemia, Neutropenic Sepsis, Pancytopenia, Rash, Superinfection Bacterial, Superinfection Fungal
Adverse event was reported on Mar 25, 2010 by a Male patient taking Temodar (View Usage) (Dosage: 380 Mg; Qd; Po) was diagnosed with brain neoplasm and. Location: UNITED STATES , 28 years of age, After Temodar was administered, patient had the following side effects: aplastic anaemia, neutropenic sepsis, pancytopenia, rash (What is rash?), superinfection bacterial, superinfection fungal. Patient was hospitalized and became disabled.

6662450-2 | Blast Cell Count Increased, Febrile Neutropenia, Haematocrit Decreased, Haemoglobin Decreased, Platelet Count Decreased
on Mar 23, 2010 Female patient from UNITED STATES , 76 years of age, weighting 121.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: blast cell count increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Temodar dosage: 100 Mg/m2; Qd; Po, 200 Mg/m2; Qd; Po, 200 Mg/m2; Qd' Po. Patient was hospitalized.

6657543-X | Asthenia, Erythema, Fatigue, Febrile Neutropenia, Haematocrit Decreased, Haemoglobin Decreased, No Therapeutic Response, Platelet Count Increased, Tongue Ulceration
on Mar 23, 2010 Male patient from UNITED STATES , 67 years of age, weighting 241.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Temodar (View Usage). Patient had the following side effects: asthenia, erythema, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased, no therapeutic response, platelet count increased, tongue ulceration. Temodar dosage: 100 Mg/m2;qd;po, 200 Mg/m2;qd;po. Patient was hospitalized.

6645840-3 |
Patient was taking Temodar (View Usage). on Mar 15, 2010 from UNITED STATES Additional patient health information: Female patient , 44 years of age, was diagnosed with malignant melanoma and. Temodar dosage: .

6644854-7 |
Adverse event was reported on Mar 15, 2010 by a Male patient taking Temodar (View Usage) (Dosage: ) was diagnosed with brain neoplasm and. Location: UNITED STATES , 69 years of age, .

6636006-1 | Abdominal Tenderness, Aspartate Aminotransferase Increased, Asthenia, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Breath Sounds Abnormal, Fatigue, Feeling Abnormal, Haemoglobin Abnormal
on Mar 08, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Temodar (View Usage). Patient had the following side effects: abdominal tenderness, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood alkaline phosphatase increased, breath sounds abnormal, fatigue, feeling abnormal, haemoglobin abnormal. Temodar dosage: 200 Mg/m2; Qd; Po; 150 Mg/m2; Qd; Po. During the same period patient was treated with SORAFENIB (View Sorafenib Review and Sorafenib Label ), TYLENOL PM (View Tylenol Pm Review and Tylenol Pm Label ), IMODIUM (View Imodium Review and Imodium Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6635615-3 | Bone Marrow Failure, Cerebral Haemorrhage
on Mar 12, 2010 Female patient from UNITED STATES , weighting 128.0 lb, was diagnosed with neoplasm and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: bone marrow failure, cerebral haemorrhage. Temodar dosage: 200 Mg Daily Pill. Patient was hospitalized and became disabled.

6625539-X | Bone Marrow Failure, Disease Progression, Infection, Multi-organ Failure
Patient was taking Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, disease progression, infection (What is infection?), multi-organ failure on Mar 01, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with glioblastoma multiforme and. Temodar dosage: 200 Mg/ M2; Qd; Po. During the same period patient was treated with PEPCID (CON.) (View Pepcid (con.) Review and Pepcid (con.) Label ), KEPPRA (CON.) (View Keppra (con.) Review and Keppra (con.) Label ), VALTREX (CON.) (View Valtrex (con.) Review and Valtrex (con.) Label ), PENTAMIDINE (CON.) (View Pentamidine (con.) Review and Pentamidine (con.) Label ), LISINOPRIL (CON.) (View Lisinopril (con.) Review and Lisinopril (con.) Label ), ZOCOR (CON.) (View Zocor (con.) Review and Zocor (con.) Label ), DECADRON (CON.) (View Decadron (con.) Review and Decadron (con.) Label ), DIFLUCAN (CON.) (View Diflucan (con.) Review and Diflucan (con.) Label ). Patient was hospitalized.

6616794-0 | Atrial Fibrillation
Adverse event was reported on Feb 22, 2010 by a Male patient taking Temodar (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 62 years of age, weighting 209.0 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), NEXIUM (View Nexium Review and Nexium Label ), CELEXA (View Celexa Review and Celexa Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), KEPPRA (View Keppra Review and Keppra Label ), NORCO (View Norco Review and Norco Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6610911-4 | Aplastic Anaemia, Atrial Fibrillation, Bacterial Sepsis, No Therapeutic Response, Pancytopenia, Shock
on Feb 11, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodar (View Usage). After Temodar was administered, patient had the following side effects: aplastic anaemia, atrial fibrillation (What is atrial fibrillation?), bacterial sepsis, no therapeutic response, pancytopenia, shock. Temodar dosage: 75 Mg/m2;qd;po. During the same period patient was treated with AVASTIN (10 Mg/kg) (View Avastin Review and Avastin Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6597794-6 | Sepsis
on Feb 09, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with brain neoplasm and was treated with Temodar (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?). Temodar dosage: 130 Mg;qd;po.

6597790-9 | Respiratory Failure
Patient was taking Temodar (View Usage). Patient had the following side effects: respiratory failure on Feb 11, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with neoplasm and. Temodar dosage: .